Quantcast

Latest BioLife Solutions Inc. Stories

2015-01-12 08:28:17

Proprietary Products Revenue Growth of 25% over 2013; HypoThermosol® and CryoStor® Now Embedded in 175 Regenerative Medicine Clinical Trials BOTHELL, Wash., Jan.

2015-01-05 08:29:29

Proprietary, Clinical Grade HypoThermosol® and CryoStor® Extending Shelf Life and Improving Survival & Function of CAR-T Cells, Dendritic Cells, Etc. BOTHELL, Wash., Jan.

2014-12-24 08:22:48

BOTHELL, Wash., Dec. 24, 2014 /PRNewswire/ -- BioLife Solutions, Inc.

2014-12-23 08:24:46

Key Executive Will Support Adoption of biologistex(SM) Cold Chain Management Service and EVO(TM) Smart Containers for Temperature Sensitive Biologics BOTHELL, Wash., Dec.

2014-11-25 08:28:40

BOTHELL, Wash., Nov. 25, 2014 /PRNewswire/ -- BioLife Solutions, Inc.

2014-11-17 08:29:19

Single-Use Syringes and Bulk Dispensing Bags with Sterile Dockable Tubing Offer Improved Aseptic Processing of Clinical Cells and Tissues BOTHELL, Wash., Nov.

2014-10-30 08:33:55

BOTHELL, Wash., Oct. 30, 2014 /PRNewswire/ -- BioLife Solutions, Inc.

2014-10-21 08:32:30

Adult Mesenchymal Stem Cells Demonstrate Enhanced Survival and Recovery Following Cryopreservation with CryoStor, Reducing Research Costs and Expansion Time BOTHELL, Wash., Oct.

2014-10-14 08:30:39

HypoThermosol® and CryoStor® Embedded in Internal Cell Therapy Candidates and Numerous Mutual Customer Regenerative Medicine Applications BOTHELL, Wash., Oct.

2014-10-06 08:27:42

Year-to-date Core Product Revenue up 27% Over 2013 BOTHELL, Wash., Oct.


Word of the Day
ultimo
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
  • In the month which preceded the present; in the last month, as distinguished from the current or present month and all others.
The word 'ultimo' comes from the Latin phrase 'ultimo mense', 'in the last month'.
Related